A quinolizidine alkaloid isolated from several FABACEAE including LUPINUS; SPARTIUM; and CYTISUS. It has been used as an oxytocic and an anti-arrhythmia agent. It has also been of interest as an indicator of CYP2D6 genotype.
Sparteine has been studied across 8 research domains including 🫁 Liver & Detox, ❤️ Cardiovascular, 🌤️ Mood & Depression, 🧠 Focus & Attention, 😴 Sleep. The primary research focus is 🫁 Liver & Detox with 8% of studies addressing this area.
The following compounds share molecular targets with Sparteine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Sparteine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.